Levitra is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, Inc.. The primary component is Vardenafil Hydrochloride.
Product ID | 43353-748_95bf61f7-6238-4b01-b70e-df731b5f642b |
NDC | 43353-748 |
Product Type | Human Prescription Drug |
Proprietary Name | Levitra |
Generic Name | Vardenafil Hydrochloride |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2011-04-22 |
Marketing Category | NDA / NDA |
Application Number | NDA021400 |
Labeler Name | APHENA PHARMA SOLUTIONS - TENNESSEE, INC. |
Substance Name | VARDENAFIL HYDROCHLORIDE |
Active Ingredient Strength | 20 mg/1 |
Pharm Classes | Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2011-04-22 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021400 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-04-22 |
Inactivation Date | 2019-11-13 |
Marketing Category | NDA |
Application Number | NDA021400 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-04-22 |
Inactivation Date | 2019-11-13 |
Marketing Category | NDA |
Application Number | NDA021400 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-04-22 |
Inactivation Date | 2019-11-13 |
Marketing Category | NDA |
Application Number | NDA021400 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-04-22 |
Inactivation Date | 2019-11-13 |
Marketing Category | NDA |
Application Number | NDA021400 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-04-22 |
Inactivation Date | 2019-11-13 |
Marketing Category | NDA |
Application Number | NDA021400 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2011-04-22 |
Inactivation Date | 2019-11-13 |
Ingredient | Strength |
---|---|
VARDENAFIL HYDROCHLORIDE | 20 mg/1 |
SPL SET ID: | 4e66ad5c-572c-4819-8b6e-6930c33cc210 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0173-0829 | Levitra | vardenafil hydrochloride |
0173-0830 | Levitra | vardenafil hydrochloride |
0173-0831 | Levitra | vardenafil hydrochloride |
43353-741 | Levitra | Levitra |
43353-748 | Levitra | Levitra |
43353-744 | Levitra | Levitra |
43353-323 | Levitra | Levitra |
55289-193 | Levitra | Levitra |
63629-3372 | Levitra | Levitra |
67544-507 | Levitra | Levitra |
67544-512 | Levitra | Levitra |
0173-0822 | Staxyn | vardenafil hydrochloride |
0093-7652 | Vardenafil Hydrochloride | Vardenafil Hydrochloride |
0093-7653 | Vardenafil Hydrochloride | Vardenafil Hydrochloride |
0093-7654 | Vardenafil Hydrochloride | Vardenafil Hydrochloride |
0093-7655 | Vardenafil Hydrochloride | Vardenafil Hydrochloride |
0527-2800 | Vardenafil Hydrochloride | Vardenafil Hydrochloride |
0527-2801 | Vardenafil Hydrochloride | Vardenafil Hydrochloride |
0527-2802 | Vardenafil Hydrochloride | Vardenafil Hydrochloride |
0527-2803 | Vardenafil Hydrochloride | Vardenafil Hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LEVITRA 78560108 3050814 Live/Registered |
Bayer Aktiengesellschaft 2005-02-03 |
LEVITRA 75913260 2622847 Live/Registered |
Bayer Aktiengesellschaft 2000-02-08 |